EPISODE · Nov 3, 2022 · 24 MIN
Dying to remember
from Inside U Miami Medicine · host University of Miami Miller School of Medicine
Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School, joins Dean Henri Ford to give insight into this devastating illness and the search for better outcomes.
Embed this episode
Ready to play
Dying to remember
No transcript for this episode yet
Similar Episodes
No similar episodes found.